PMID: 16518128Mar 7, 2006Paper

Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study

Clinical Neuropharmacology
Eitan AurielN Giladi

Abstract

Twenty-one patients with Parkinson's disease were studied before and 2 h after the administration of a single dose of 20 mg of methylphenidate. In response to methylphenidate, attention significantly improved, whereas memory and visual-spatial performance were unchanged. Gait speed, stride time variability, and Timed Up and Go times (demonstrated measures of fall risk) significantly improved. These findings suggest a new potential pharmacologic means of enhancing mobility and decreasing fall risk in Parkinson's disease.

References

Apr 1, 1996·Brain : a Journal of Neurology·M E MorrisJ J Summers
Aug 9, 2001·Archives of Physical Medicine and Rehabilitation·J M HausdorffH K Edelberg
Nov 5, 2003·BMC Geriatrics·Tzvi DwolatzkyHoward Chertkow
Jun 3, 2004·Annals of Neurology·John G NuttGary J Sexton
May 3, 2005·Experimental Brain Research·Jeffrey M HausdorffNir Giladi
Sep 24, 2005·The European Journal of Neuroscience·Galit YogevJeffrey M Hausdorff

❮ Previous
Next ❯

Citations

Oct 17, 2009·European Journal of Clinical Pharmacology·Peter Klivenyi, Laszlo Vecsei
Apr 3, 2007·Journal of Neurology·Yael LeitnerJeffrey M Hausdorff
May 21, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Talia HermanJeffrey M Hausdorff
Nov 14, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·D DevosL Defebvre
May 21, 2010·Gerontology·Talia HermanJeffrey M Hausdorff
Apr 17, 2013·Journal of Neuroengineering and Rehabilitation·Eliraz Seri-FainshtatJeffrey M Hausdorff
Oct 31, 2013·International Psychogeriatrics·Krista L LanctôtJacobo E Mintzer
Nov 30, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Barbara Connolly, Susan H Fox
Dec 7, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Albert Y Hung, Michael A Schwarzschild
Apr 13, 2013·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Zamir ShorerItshak Melzer
Jun 5, 2014·Brain : a Journal of Neurology·Angie A KehagiaTrevor W Robbins
Dec 21, 2013·Expert Opinion on Pharmacotherapy·Naren P Rao, Gary Remington
May 4, 2013·Expert Opinion on Investigational Drugs·Naren P Rao, Gary Remington
Sep 18, 2013·Disability and Rehabilitation·Kathleen M ZackowskiJoanne M Wagner
Mar 27, 2015·Parkinson's Disease·Philippe HuotJonathan M Brotchie
May 16, 2014·The International Journal of Neuropsychopharmacology·Olivia M FarrChiang-Shan R Li
Feb 7, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Michelle H Cameron, Garnett McMillan
Dec 12, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Lorraine V KaliaSusan H Fox
Oct 30, 2014·International Journal of Geriatric Psychiatry·Shih-Wei HuangHui-Wen Lin
Nov 1, 2012·Journal of the American Geriatrics Society·Manuel Montero-OdassoJeffrey M Hausdorff
Apr 7, 2007·Clinical Neuropharmacology·Diana PaleacuJeffrey M Hausdorff
Dec 7, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Galit Yogev-SeligmannNir Giladi
Nov 4, 2008·Clinical Neuropharmacology·Eitan AurielNir Giladi
Jul 9, 2008·Current Opinion in Neurology·Tjitske A BoonstraBastiaan R Bloem
Nov 11, 2008·Annals of the New York Academy of Sciences·Trent J VolzAnnette E Fleckenstein
Feb 19, 2010·Fundamental & Clinical Pharmacology·David DevosR Bordet
Aug 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Nir Giladi
Aug 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Yasuyuki Okuma, Nobuo Yanagisawa
Aug 5, 2010·Ophthalmic Plastic and Reconstructive Surgery·Kristina M PriceJulie A Woodward
Feb 13, 2009·Expert Review of Neurotherapeutics·Yvette A M GrimbergenBastiaan R Bloem
Jun 23, 2009·Bipolar Disorders·Joseph F Goldberg, K N Roy Chengappa
Jul 5, 2011·Expert Review of Neurotherapeutics·Orit Segev-JacubovskiJeffrey M Hausdorff
Dec 15, 2012·Expert Review of Neurotherapeutics·Barbara S Connolly, Susan H Fox
Jan 11, 2018·Journal of the American Geriatrics Society·Manuel Montero-Odasso, Mark Speechley
Aug 17, 2019·Expert Review of Neurotherapeutics·Martijn L T M MüllerNicolaas I Bohnen
Aug 28, 2019·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Stephen JozaFang Ba

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique
M DiopJ Cottalorda
© 2021 Meta ULC. All rights reserved